Total Payments
$6,860
2024 Payments
$89.13
Companies
46
Transactions
337
Medicare Patients
2,974
Medicare Billing
$303,805
Payment Breakdown by Category
Food & Beverage$6,790 (99.0%)
Education$70.78 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,790 | 333 | 99.0% |
| Education | $70.78 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,051 | 52 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $636.45 | 30 | $0 (2023) |
| UCB, Inc. | $398.78 | 16 | $0 (2023) |
| AbbVie Inc. | $371.40 | 26 | $0 (2023) |
| GENZYME CORPORATION | $314.17 | 10 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $294.29 | 17 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $283.39 | 13 | $0 (2023) |
| Celgene Corporation | $240.83 | 12 | $0 (2023) |
| Lilly USA, LLC | $231.93 | 11 | $0 (2023) |
| Amgen Inc. | $223.23 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.13 | 1 | DePuy Synthes Sales Inc. ($89.13) |
| 2023 | $2,295 | 102 | Alexion Pharmaceuticals, Inc. ($319.47) |
| 2022 | $2,462 | 130 | Biogen, Inc. ($494.86) |
| 2021 | $1,869 | 102 | Biogen, Inc. ($285.96) |
| 2020 | $19.56 | 1 | Eisai Inc. ($19.56) |
| 2018 | $125.00 | 1 | GENZYME CORPORATION ($125.00) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | DePuy Synthes Sales Inc. | MATRIXMANDIBLE (Device), MATRIXMIDFACE | Food and Beverage | In-kind items and services | $89.13 | General |
| Category: CMF-Trauma | ||||||
| 11/30/2023 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Neurology | ||||||
| 11/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $28.63 | General |
| Category: Neuroscience | ||||||
| 11/20/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Rare Disease | ||||||
| 11/16/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: Neurology | ||||||
| 11/15/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 11/15/2023 | Catalyst Pharmaceuticals, Inc. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: PAIN | ||||||
| 11/08/2023 | Biogen, Inc. | TYSABRI (Biological), AVONEX, VUMERITY | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neurology | ||||||
| 11/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Rare Disease | ||||||
| 11/07/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neuroscience | ||||||
| 10/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Neurology | ||||||
| 10/24/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: NEUROLOGY | ||||||
| 10/20/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: PAIN | ||||||
| 10/18/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Neurology | ||||||
| 10/16/2023 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 10/10/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Immunology | ||||||
| 10/09/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Neurology | ||||||
| 09/21/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Rare Disease | ||||||
| 09/19/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $21.00 | General |
| 09/07/2023 | Genentech USA, Inc. | Enspryng (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 932 | 1,122 | $188,412 | $95,241 |
| 2022 | 11 | 926 | 1,110 | $157,485 | $85,365 |
| 2021 | 13 | 1,023 | 1,291 | $199,847 | $115,027 |
| 2020 | 3 | 93 | 94 | $21,334 | $8,172 |
Total Patients
2,974
Total Services
3,617
Medicare Billing
$303,805
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 271 | $52,520 | $25,520 | 48.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 139 | 167 | $45,092 | $23,192 | 51.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 102 | 162 | $11,870 | $6,427 | 54.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 84 | $9,756 | $5,305 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 75 | $10,278 | $4,814 | 46.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 42 | 42 | $8,520 | $4,542 | 53.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 40 | $7,813 | $4,156 | 53.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $8,580 | $3,975 | 46.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 50 | 50 | $7,233 | $3,813 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $7,371 | $3,626 | 49.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 41 | 41 | $5,791 | $2,722 | 47.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 55 | 57 | $4,872 | $2,539 | 52.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 43 | 44 | $3,708 | $1,960 | 52.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $3,206 | $1,702 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 18 | $1,802 | $947.52 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 229 | 313 | $54,191 | $30,265 | 55.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 67 | $15,588 | $9,806 | 62.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 115 | $12,880 | $6,675 | 51.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 58 | 58 | $12,296 | $6,280 | 51.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $12,264 | $6,174 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 77 | $9,339 | $4,839 | 51.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 85 | 88 | $7,920 | $4,171 | 52.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 47 | $7,614 | $3,963 | 52.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 75 | 114 | $6,954 | $3,557 | 51.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 65 | 68 | $6,120 | $3,127 | 51.1% |
About Saiqa Choudhry
Saiqa Choudhry is a Neurology healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1043508450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Saiqa Choudhry has received a total of $6,860 in payments from pharmaceutical and medical device companies, with $89.13 received in 2024. These payments were reported across 337 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($6,790).
As a Medicare-enrolled provider, Choudhry has provided services to 2,974 Medicare beneficiaries, totaling 3,617 services with total Medicare billing of $303,805. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cumberland, MD
- Active Since 07/19/2011
- Last Updated 02/20/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1043508450
Products in Payments
- TYSABRI (Biological) $606.47
- Briviact (Drug) $359.50
- ULTOMIRIS (Biological) $298.64
- AVONEX (Biological) $297.74
- ZEPOSIA (Drug) $263.71
- EMGALITY (Drug) $231.93
- QULIPTA (Drug) $226.34
- Aimovig (Biological) $223.23
- PURIFIED CORTROPHIN GEL (Drug) $218.98
- RYTARY (Drug) $214.96
- AUBAGIO (Drug) $189.17
- Soliris (Drug) $184.67
- RADICAVA (Drug) $165.65
- AUSTEDO (Drug) $163.63
- VALTOCO (Drug) $156.76
- Ongentys (Drug) $138.53
- Fycompa (Drug) $134.13
- SOLIRIS (Biological) $128.30
- UBRELVY (Drug) $128.18
- VUMERITY (Drug) $126.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cumberland
Dr. Murtaza Amir, M.d, M.D
Neurology — Payments: $9,538
Neurology $9,538
Dr. Alla Korennaya, M.d, M.D
Neurology — Payments: $4,821
Neurology $4,821
Dr. Iakov Rudenko, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $630.48
Neurology $630.48
T Collins, Do, DO
Neurology — Payments: $163.60
Neurology $163.60